Gilead Sciences planning to produce the amount of its potential COVID-19 drug remdesivir by the end of the year
- It says it'll begin trial of an easier-to-use inhaled version in August (its currently administered intravenously)
- inhaled formulation would be via a nebulizer, whoich would make its use easier outside of in-patient at hospital
This was out overnight, not fresh news,
